CGNOF Recent News Emergent BioSolutions Completes
Post# of 3
Emergent BioSolutions Completes Acquisition of Cangene Corporation Business Wire - Fri Feb 21, 10:20AM CST
Emergent BioSolutions Announces Completion of $250 Million Convertible Senior Notes Offering Business Wire - Wed Jan 29, 3:01PM CST
Emergent BioSolutions Announces Expiration of the Hart-Scott-Rodino Waiting Period for Emergent's Acquisition of Cangene Corporation Business Wire - Tue Jan 28, 6:00AM CST
Emergent BioSolutions Announces Pricing of Offering of $215 Million of 2.875% Convertible Senior Notes Business Wire - Thu Jan 23, 6:58PM CST
Emergent BioSolutions Announces Proposed Offering of $200 Million Convertible Senior Notes Business Wire - Wed Jan 22, 3:01PM CST
Global Hemophilia Clinical Trials Review, H2 2013 Analysis M2 - Tue Oct 15, 9:20AM CDT
Global Smallpox Clinical Trials Review, H2, 2013 M2 - Tue Oct 15, 9:20AM CDT
IIROC Trade Resumption - Cangene Corporation Newsfile Corp - Thu Sep 19, 9:55AM CDT
IIROC Trade Halt - Cangene Corporation Newsfile Corp - Thu Sep 19, 8:32AM CDT
Hemophilia - Pipeline Review, H2 2013 M2 - Tue Sep 10, 3:30AM CDT